Together, the current study highlights that LL-37 can ameliorate the progression of ALI caused by sepsis in in vitro and in vivo models by suppressing oxidative injury and the inflammatory response, concomitant with ZBP1 down-regulation and autophagy activation. Here, ZBP1 is linked to Sepsis.